FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2181345 · Received July 21, 2011

Report

Report Number
9612164-2011-00799
Event Type
Injury
Date Received
July 21, 2011
Date of Event
February 8, 2008
Report Date
July 7, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: (MYOCARDIAL INFARCTION & REVASCULARIZATION).

Description of Event or Problem · 1

THE PT HAD ONE ENDEAVOR RX DRUG ELUTING STENT IMPLANTED TO THE PROXIMAL LAD. THE NEXT DAY, DURING A PLANNED STAGED PROCEDURE, THE PT HAD ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 1ST OBTUSE MARGINAL. FOLLOWING REVIEW BY THE CLINICAL EVENTS COMMITTEE, IT IS REPORTED THAT A NON Q-WAVE MI OCCURRED ON THE SAME DAY. FOUR DAYS LATER, DURING A PLANNED STAGED PROCEDURE, THE PT HAD ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 1ST LEFT POSTEROLATERAL BRANCH. THE PT WAS ASYMPTOMATIC AT 30 DAY, 6 MONTH, 1 YEAR AND 1.5 YEAR F/U. ONE WEEK POST 1.5 YEAR F/U THE PT SUFFERED A NON Q-WAVE MI LOCATION OF THE INFARCTION WAS NON-DETERMINABLE. REVASCULARIZATION (PTCA) WAS PERFORMED ON THE SAME DAY WITH ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 2ND LEFT POSTEROLATERAL BRANCH. INDICATION FOR INTERVENTION WAS POSITIVE HISTORY OR RECURRENT ANGINA PECTORIS PRESUMABLY RELATED TO THE TARGET VESSEL. INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT. THE PT WAS TAKING CLOPIDOGREL & ASPIRIN 24 HRS PRIOR TO EVENT. (REF MFR # 9612164201100800 & 9612164201100801).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA 0000542487

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention